Carnegie Commissioned Research: EQL Pharma: Margin recovery, good cost control – Q1(24/25) initial comment
Carnegie has published a new flash comment on EQL Pharma following recent news flow.
To access the full report and subscribe to future updates, visit https://www.carnegie.se/en/commissioned-research/eql-pharma/